|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-3-19
|
|
pubmed:abstractText |
The authors designed a randomized, double-blind, crossover study to assess the efficacy of sertraline in the treatment of premenstrual dysphoric disorder (PMDD) when given only during the luteal phase of the menstrual cycle.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0160-6689
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
59
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
76-80
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9501889-1-Naphthylamine,
pubmed-meshheading:9501889-Adult,
pubmed-meshheading:9501889-Comorbidity,
pubmed-meshheading:9501889-Depressive Disorder,
pubmed-meshheading:9501889-Double-Blind Method,
pubmed-meshheading:9501889-Drug Administration Schedule,
pubmed-meshheading:9501889-Female,
pubmed-meshheading:9501889-Humans,
pubmed-meshheading:9501889-Luteal Phase,
pubmed-meshheading:9501889-Medical Records,
pubmed-meshheading:9501889-Personality Inventory,
pubmed-meshheading:9501889-Placebos,
pubmed-meshheading:9501889-Premenstrual Syndrome,
pubmed-meshheading:9501889-Questionnaires,
pubmed-meshheading:9501889-Serotonin Uptake Inhibitors,
pubmed-meshheading:9501889-Sertraline
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial.
|
|
pubmed:affiliation |
Department of Psychiatry, Walter Reed Army Medical Center, Washington, D.C., USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, Non-P.H.S.,
Randomized Controlled Trial
|
